Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment patterns after abiraterone acetate in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis of COU-AA-302
    Meeting Abstract

    Flaig, T. W.; Smith, M. R.; Saad, F.; Rathkopf, D. E.; Mulders, P. F. A.; Small, E. J.; Shore, N. D.; Fizazi, K.; De Porre, P.; Kheoh, T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Metastasis-associated mutations in clear cell renal cell carcinoma
    Meeting Abstract

    Gowrishankar, B.; Janakiraman, M.; Lee, C. H.; Thodima, V. J.; Molina, A. M.; Patel, P. H.; Gold, T. M.; Motzer, R. J.; Chaganti, R. S. K.; Kamalakaran, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • [(18)F] NaF PET/CT imaging biomarkers of progression-free survival in metastatic prostate cancer
    Meeting Abstract

    Harmon, S.; Perk, T.; Eickhoff, J. C.; Staab, M. J.; Choyke, P. L.; Dahut, W. L.; Apolo, A. B.; Humm, J.; Larson, S. M.; Morris, M. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical validation of CTC subtype frequency to prognosis OS in mCRPC patients
    Meeting Abstract

    Dittamore, R. V.; Louw, J.; Schreiber, N. A.; Graf, R.; Jendrisak, A.; Johnson, A.; Dugan, L.; McLaughlin, B.; Heller, G.; Fleisher, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Investigation of a frequently mutated transcriptional repressor in prostate cancer, in particular its role in modulating androgen signaling and its effects on TMPRSS2-ERG dependent tumor maintenance
    Meeting Abstract

    Bose, R.; Abida, W.; Iaquinta, P.; Karthaus, W.; Armenia, J.; Wongvipat, J.; Doran, M.; Hieronymus, H.; Philip, W.; Liang, Y. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis
    Meeting Abstract

    Cosgriff, T.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L. P.; Kowalyszyn, R. D.; Karyakin, O.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis
    Meeting Abstract

    Cosgriff, T.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L. P.; Kowalyszyn, R. D.; Karyakin, O.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Integrated genomic correlates of response to PD-1 inhibitor nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    de Velasco, G.; Miao, D.; Shukla, S.; Voss, M. H.; Wu, C.; Murray, B.; Meyerson, M.; Signoretti, S.; Motzer, R. J.; Van Allen, E. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Brennan, R.; Armenia, J.; Curtis, K. R.; Gopalan, A.; Arcila, M. E.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save